M. Kate Bundorf is Associate Professor of Health Research and Policy at the Stanford University School of Medicine; Associate Professor, by courtesy, at the Stanford Graduate School of Business; and a Stanford Health Policy Fellow. She is also Faculty Research Fellow at the National Bureau of Economic Research. She received her MBA and MPH from the University of California at Berkeley and her PhD from the Wharton School. She was a Fulbright lecturer and visiting professor at Fudan School of Public Health in Shanghai, China, in 2009 and 2010. Her research, which focuses on health insurance markets, has been published in leading economics and health policy journals and has received funding from the US National Institutes of Health, the Agency for Health Care Research and Quality, and the Robert Wood Johnson Foundation. Specific research topics include the determinants and effects of individual and purchaser choices, the effects of regulation in insurance markets, the interaction of public and private systems of health insurance, and incentives for insurers to improve healthcare quality. Bundorf received the 13th Annual Health Care Research Award from the National Institute for Health Care Management in 2007.

Lawton Robert Burns is the James Joo-Jin Kim Professor, Professor of Health Care Management, and Professor of Management in the Wharton School at the University of Pennsylvania. He is also Director of the Wharton Center for Health Management & Economics and Co-Director of the Roy & Diana Vagelos Program in Life Sciences and Management. He received his doctorate in Sociology and his MBA in Health Administration from the University of Chicago. Dr. Burns taught previously in the Graduate School of Business at the University of Chicago and in the College of Business Administration at the University of Arizona.

Dr. Burns has analyzed physician–hospital integration and integrated delivery networks over the past 30 years. In recognition of this research, Dr. Burns recently received the 2015 Distinguished Research Scholar Award from the Academy of Management and its Health Care Administration Division. He was named the Edwin L. Crosby Memorial Fellow by the Hospital Research and Educational Trust in 1992. Dr. Burns has also published several papers on hospital systems, physician group practices, accountable care organizations (ACOs), managed care, and price transparency. He spent the last 15 years studying the healthcare supply chain. He completed a book on supply chain management in the healthcare industry, The Health Care Value Chain (Jossey-Bass, 2002), and a recent analysis of alliances between imaging equipment makers and hospital systems. These studies focus on the strategic alliances and partnerships developing between pharmaceutical firms/distributors, disposable manufacturers, medical device manufacturers, group purchasing organizations, and organized delivery systems. He has also edited The Business of Healthcare Innovation (Cambridge University Press, 2012), which analyzes the healthcare technology sectors globally: pharmaceuticals, biotechnology, medical devices, and information technology. Most recently, he has served as lead editor of the sixth edition of the major text Healthcare Management: Organization Design & Behavior (Delmar, 2011). His latest book is India’s Healthcare Industry (Cambridge University Press, 2014).

Tsung-Mei Cheng, JD, MA, is Health Policy Research Analyst at the Woodrow Wilson School of Public and International Affairs, Princeton University, USA. Cheng’s current research focuses on cross-national comparisons of health systems in East Asia, health reforms in China and Taiwan, health technology assessment and comparative effectiveness research, healthcare quality, financing, payment reform, including evidence-based clinical guidelines and clinical pathways, and pay for performance (P4P) in East Asian health systems.

Cheng is an advisor to the National Institute for Health and Care Excellence International (NICE International) of the United Kingdom, which advises governments and agencies overseas on capacity-building for evidence base to inform national health policy as well as knowledge transfer among decision makers across national borders. She is also an advisor to the China National Health Development Research Center (CNHDRC), the official Chinese government think tank for health policy under China’s National Health and Family Planning Commission (formerly the Ministry of Health). In addition, Cheng serves as a special advisor to the Center for the Study of Major Policies (CSMP), Tsinghua University, China. Cheng is a member of the editorial board of Health Affairs, the leading US health policy journal. Cheng is also a member of the Emerging Market Symposium (EMS) Steering Committee – an Oxford University–based initiative that addresses pressing sectoral issues facing emerging market countries.

James Deng is one of the most influential healthcare industry leaders in China with over 25 years’ management experience in multinational companies. He was the first healthcare MNC China CEO with Chinese nationality when he was appointed as the president and CEO for Novartis Pharma China back in 2006. He is now Vice President, General Manager for Becton, Dickinson and Company Greater China, and also the elected Chairman of AdvaMed China Council Board for two consecutive terms. James has lectured on healthcare strategy in emerging markets in Wharton School MBA classes. James is a physician by training and also a graduate from China Europe International Business School (CEIBS) MBA class and Harvard General Management Program (GMP).

Karen Eggleston is Senior Fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford University and Director of the Stanford Asia Health Policy Program at the Walter H. Shorenstein Asia-Pacific Research Center at FSI. She is also Senior Fellow with the Center for Innovation in Global Health at the Stanford University School of Medicine and Faculty Research Fellow of the National Bureau of Economic Research. Eggleston earned her PhD in Public Policy from Harvard University in 1999. She has an MA in Economics and Asian Studies from the University of Hawaii and a BA in Asian Studies summa cum laude (valedictorian) from Dartmouth College. Eggleston studied in China for two years and was a Fulbright scholar in Korea. Her research focuses on comparative healthcare systems and health reform in Asia, especially China; government and market roles in the health sector; payment incentives; healthcare productivity; and the economics of the demographic transition. She was a consultant to the World Bank on their project on health service delivery in rural China in 2004, to China’s Ministry of Finance and the Asian Development Bank from 2010 to 2011 for an evaluation of China’s health reforms, and to the World Bank/WHO/Government of China 2015 study on China’s health service delivery system. She is a member of the Strategic Technical Advisory Committee for the Asia Pacific Observatory on Health Systems and Policies.

Vanessa Folkerts is Senior Manager for External Partnerships and Initiatives at United Family Healthcare (UFH, 和睦家医疗). UFH, the healthcare services division of Chindex International Inc., operates an expanding network of hospitals and clinics throughout mainland China, and is the only Joint Commission International–accredited healthcare system in Asia. She has been leading transactions ranging from the partial acquisition of Mongolia’s first high-end private hospital in 2014 to the development of international referral networks for medical tourism and the opening of one of China’s largest surgical training centers in 2015. She is currently managing a public–private partnership to establish China’s first US-accredited medical school. Prior to working at UFH, Vanessa worked at Cedars-Sinai Medical Center in the Center for Neurosurgical Outcomes Research. She graduated from Princeton University with a BA in East Asian Studies.

Yanzhong Huang is Senior Fellow for Global Health at the Council on Foreign Relations and Professor and Director of the Center for Global Health Studies at Seton Hall University’s School of Diplomacy and International Relations. He is the founding editor of Global Health Governance: The Scholarly Journal for the New Health Security Paradigm. Huang has written extensively on global health governance and public health in China. He has published numerous reports, journal articles, and book chapters, including articles in Survival, Foreign Affairs, Journal of Health Politics, Policy and Law, as well as op-ed pieces in the New York Times, International Herald Tribune, and the Lancet, among others. He is author of Governing Health in Contemporary China (Routledge 2013). He is frequently consulted by major media outlets, the private sector, and governmental and nongovernmental organizations on global health issues and China. He has taught at Barnard College and Columbia University. He received his BA and MA from Fudan University and PhD from the University of Chicago.

Sam Krumholz is currently in the PhD program in Economics at the University of California, San Diego, where he is focusing on labor, environmental, and development economics. Sam has worked with the PKU China Center for Health Economic Research (PKU CCHER) on several projects relating to the economic and health effects of China’s recent healthcare reform. Prior to beginning his PhD, Sam received a master’s in Public Policy from the University of California, Los Angeles, where he worked on domestic health policy issues.

Ambar La Forgia is a doctoral student at the Department of Health Care Management and in the Wharton School, University of Pennsylvania. Ambar’s research focuses on the industrial organization of healthcare, particularly, integrated healthcare, physician networks, physician practice management, and the role of competition on hospital and physician cost and quality. To further these interests, Ambar worked as a summer associate with the Congressional Budget Office to study competition on the healthcare exchanges. She is funded by the National Science Foundation graduate research fellowship in Economics.

Prior to her doctoral studies, Ambar worked in Washington DC as a policy analyst for the Quantitative Economics and Statistics (QUEST) group of Ernst and Young. At QUEST, she worked exclusively on health industry topics, including company compliance with the Medical Device Excise Tax and nonprofit hospital compliance with uncompensated care requirements. Ambar holds a BA from Swarthmore College, where she graduated in 2011 from the honors program in Economics and Mathematics.

Gerard M. La Forgia is Lead Health Specialist at the World Bank, currently working out of Washington for the East Asia Region with primary responsibility for China. He was formerly the bank’s lead health specialist in India, Brazil, and Central America. He has published books on service delivery reform in China (2016), health insurance in India (2012), hospital performance in Brazil (2008), and health systems reforms in Central America (2005). He is also the author of a number of articles and technical reports on health systems in developing countries. Before joining the World Bank, he was a research associate at the Urban Institute and a senior health specialist at the Inter-American Development Bank. He has a ScD in Health Service Administration from the University of Pittsburgh.

Rachel Lee has been advising companies on their China strategy for over a decade. She was a partner and managing director of the Boston Consulting Group in its Shanghai office. In this capacity, she co-led the healthcare practice, published viewpoints, and spoke at industry conferences. She also briefly served as the country manager for Shire Pharmaceuticals prior to returning to the United States. Rachel holds an MBA from the Wharton School. She is a native of Nanjing, China and currently lives in San Diego, California.

Xiaofeng Liang is Deputy Director of the Chinese Center for Disease Control and Prevention (China CDC) and Director of the Tobacco Control Office of China CDC since 2011. Dr. Liang earned his medical degree at Shanxi Medical University in 1984 and then went to Gansu Province and served as a staff member of Gansu Health Bureau (1984–1992). Between 1993–1995, he obtained his Master’s in Public Health from the College of Public Health of Peking University of Medicine. After that, he was an exchange scholar at the Department of Psychiatry and Behavioral Sciences, College of Medicine, University of Miami, Florida, USA (1996–1998).

He returned to China in 1998 and was the vice-director of Epidemic Prevention Station of Gansu Province (1999–2000), vice-director of the Institute of Epidemiology and Microbiology, Chinese Academy of Preventive Medicine (2000–2001), and the director of National Immunization Program, the subcenter of China CDC (2001–2011).

He was a member of the Global Strategic Advisory Group of Experts on Immunization from 2008 to 2013. He was also a member of the Chinese Committee Advisory of Immunization Practice, Chinese Association of Community Health, and Chinese Association of Prevention Medicine (Branch of Biological Products).

As the deputy director of China CDC, his research in public health led to advances in immunization, vaccination, and vaccine-preventable disease control in China. Currently, he has switched to non-communicable diseases control, nutrition, and tobacco control. He is the author of more than 30 articles in national and international journals, such as the Lancet and the New England Journal of Medicine.

Roberta Lipson is Chief Executive Officer and President of United Family Heathcare (UFH), Chindex International, Inc. Roberta co-founded Chindex in 1981 and launched the United Family Healthcare hospital brand in 1997. Under her direction, UFH has become the market leader in high-end private healthcare in China. In 2015, Lipson secured financing for the expansion of the healthcare system in a buyout that valued the company at $463 million. Lipson is an active member of the business community in Beijing. She is a governor of the American Chamber of Commerce – China, a director of the US–China Business Council, and chairwoman of the United Foundation for China’s Health, the charitable arm of Chindex. Lipson holds a BA from Brandeis University and an MBA from Columbia University.

Gordon G. Liu is a PKU Yangtze River Scholar Professor of Economics at Peking University (PKU) National School of Development, Vice-Chairman of PKU Faculty of Economics and Management, and Director of PKU China Center for Health Economic Research (PKU CCHER). His research interests include health and development economics, health reform, and pharmaceutical economics. Prior to PKU National School of Development, he was a full professor at PKU Guanghua School of Management (2006–2013); associate professor at the University of North Carolina at Chapel Hill (2000–2006); and assistant professor at the University of Southern California (1994–2000). He was the 2004–2005 President of the Chinese Economists Society and the founding chair of Asian Consortium for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Dr. Liu has served as associate editor for academic journals including Health Economics, Value in Health (The ISPOR official journal), and China Economic Quarterly. Dr. Liu sits on China’s State Council Health Reform Expert Advisory Committee and the UN SDSN Leadership Council, where he co-chairs the Health Thematic Group.

Nan Luo is Assistant Professor in Saw Swee Hock School of Public Health at the National University of Singapore (NUS). Before joining NUS, Dr. Nan Luo was a research fellow at the University of Alberta and Institute of Health Economics (Alberta, Canada). As a health services researcher, Nan Luo’s research interests are measurement of patient-reported outcomes and economic evaluation of health technologies. His main expertise is developing and validating measures of patient-reported outcomes and health-state utilities. Nan Luo has authored and co-authored more than 100 original research papers in peer-reviewed journals.

Steven M. Sammut currently holds an appointment as Senior Fellow, Health Care Management, and Lecturer, Entrepreneurship, at the Wharton School of the University of Pennsylvania, and visiting faculty at the healthcare programs at the Indian School of Business, the Strathmore Business School, and the Recanati School of Tel Aviv University. He teaches and lectures extensively on the biotechnology industry, its growth prospects, and its responsibilities for serving global needs. His research focuses on human resource capacity building in healthcare and life sciences in the emerging markets.

His 40-year career has included numerous roles as a founder and CEO of biotechnology companies, as well as a partner in biotechnology venture capital funds. He holds graduate and undergraduate degrees from Villanova University in biological sciences and ethics, holds an MBA from the Wharton School, and is a DBA candidate at the Fox School of Business at Temple University.

Claudia Süssmuth-Dyckerhoff has been Senior Partner at McKinsey’s Greater China Office and has been with McKinsey for more than 20 years – the last 11 years in China/Asia. She led McKinsey’s Asia Health Systems and Services Practice and co-led McKinsey’s Greater China Healthcare Practice. She joined McKinsey in 1995 in Switzerland. Since then, she has focused on working for healthcare companies – pharmaceutical/medical device companies, payor, provider and health systems in Europe, the United States, and, since January 2006, in Greater China and across Asia. In 1998, she joined the New Jersey Office for a 15-month period.

Most of her recent work focuses on market entry or market growth strategies, business development, assessment of potential privatization assets in the health services arena, commercial excellence, organizational redesign and capability building, post-merger integration, and operational performance improvement in hospitals.

In March 2016, she got elected as Board Member of Roche and in April 2016 she got elected as Board Member of Clariant. For McKinsey, she now acts as Senior Advisor.

Claudia holds a PhD in Business Administration from the University of St. Gallen/University of Michigan, Ann Arbor, focusing on strategy and organization, and she holds an MBA from ESADE in Barcelona. She publishes regularly on consumer and healthcare trends in China and is the proud mother of four boys and a little girl.

Florian Then is Partner at McKinsey’s Shanghai office where he is a co-leader of McKinsey’s Greater China Healthcare Practice. He joined McKinsey in 2007 and has since worked extensively with health systems, healthcare providers, and in the health insurance field. He has spent seven years in China. Florian is a physician by background, trained in Munich, Boston, and Nanjing. He completed his doctoral thesis in tumor immunology. After working in clinical medicine for some time, he moved on to pursue postdoctoral studies at Institute for Neurodegenerative Disease at Massachusetts General Hospital.

Margaret Triyana is currently Assistant Professor at the Division of Economics at Nanyang Technological University, Singapore. She holds a PhD and a BS from the University of Chicago, and was previously the Asia Health Policy Postdoctoral Fellow at the Shorenstein Asia-Pacific Research Center at Stanford University. Triyana’s main research interest lies at the intersection of development and health economics, particularly regarding how social policies affect health outcomes for the poor, early health investments, and health-seeking behavior in limited resource settings. Her recent work includes measuring the effects of a conditional cash transfer on healthcare prices and the long-run effects of a community-based midwife program.

Yan Wang (王燕) is Deputy Director of the Division of Disease Control and Prevention, Health and Family Planning Commission of Shandong Province. She earned her PhD from Shandong University in 2007 and was a visiting scholar with the Asia Health Policy Program at the Shorenstein Asia-Pacific Research Center, FSI, Stanford University, in 2009–2010.

John Whitman has been active in the field of aging and long-term care for over 30 years. For the past 29 years, he has taught at the University of Pennsylvania’s Wharton MBA Healthcare Management Program and has twice received the coveted Excellence in Teaching Award. John is on the Board of the Philadelphia Corporation for Aging (PCA), the third largest Area Agency for Aging in the nation, and recently completed a term on the Dean’s Advisory Board of Drexel University’s School of Public Health.

John is a graduate of the Wharton MBA Healthcare Management Program and an active member in the Alumni Association, where he served as president and received the Alumni Achievement Award. He has also taught at LaSalle University, Villanova University, and the University of Pennsylvania’s School of Nursing. In addition, John has presented at over 400 national, state, and local professional organizations on a wide array of topics related to care of seniors.

Winnie Yip is Professor of Health Policy and Economics at the Blavatnik School of Government, University of Oxford, and Senior Research Fellow of Green Templeton College, Oxford, where she directs the Global Health Policy Program. She is also Adjunct Professor of International Health Policy and Economics at Harvard School of Public Health, where she was a faculty member before moving to Oxford. Winnie received her PhD in Economics from the Massachusetts Institute of Technology and BA in Economics from the University of California, Berkeley.

Winnie’s primary research interests include: (1) the design, implementation, and evaluation of health system interventions for improving affordable and equitable access and delivery of quality healthcare, especially for those most in need and (2) modeling and evaluating the effects of incentives on the behavior of providers (organization and individual) and patients. In addition, she is an expert on China’s healthcare system. Her works have been funded, among others, by the Bill and Melinda Gates Foundation, the Health Result Innovation Trust Fund (HRITF) of the World Bank, the National Science Foundation (US), the European Union Commission and the Economics and Social Science Research Council (UK).

Winnie is a member of the Institute of Medicine (US) Standing Committee to Support USAID’s Engagement in Health Systems Strengthening, the United Nations Sustainable Development Solutions Network’s Health for All Thematic Group on the post-2015 sustainable development goals and strategies, and the Lancet Global Surgery Commission to promote affordable access and delivery of effective and safe surgical care worldwide. She has served as consultant to the World Bank and the World Health Organization and has extensive executive training experience in Asia, especially China. In addition, she is Associate Editor of Health Economics, The Journal of the Economics of Ageing, and Health Systems and Reform, and an editorial board member of Health Policy, Health Economics, Policy and Law(Cambridge University Press).

Zhongyun Zhao is Director of Global Health Economics at Amgen. Before joining Amgen, Dr. Zhao worked for Merck-Medco, Eli Lilly, and Johnson & Johnson in the United States and China National Commission of Development and Reform in Beijing, China. He received his PhD in Economics from the University of Southern California. His research interests include health economics, outcomes research, market access, and health policy, primarily in therapeutic areas of oncology, neuroscience, and cardiovascular disease. Dr. Zhao has authored and co-authored more than 250 manuscript, poster, and abstract publications.

Sen Zhou is a doctoral student in Economics of Education and International Comparative Education program at the Stanford Graduate School of Education. She holds a BA in Law from Beijing International Studies University and an MA in Economics of Education from Peking University. Her interests include higher education, educational choices, health economics, and literacy development. Her dissertation is on the distribution of higher education opportunities in China.